目的 对1 108 例新生儿呼吸衰竭病例的临床流行病学特征进行分析,为提高临床治疗水平和开展多中心临床研究提供参考。方法 采用统一调查表收集1 108 例呼吸衰竭新生儿的临床资料,对原发疾病、临床治疗方法、治疗结局、病死率等流行病学指标进行统计学分析。结果 1 108 例患儿中位胎龄为37+1 周,中位出生体重为2 600 g,入NICU 中位日龄为0.71 d(17 h),男/ 女比例为3.1:1。主要原发疾病为呼吸窘迫综合征(30.51%)、肺部感染/ 败血症(23.55%)和湿肺(13.18%)。治疗中采用经鼻持续气道正压通气(nCPAP)占48.64%,高频振荡通气占12.81%、使用肺表面活性物质占13.45%、NO 吸入治疗占8.66%,病死率达24.19%。结论 呼吸窘迫综合征为新生儿呼吸衰竭的主要原发疾病,使用肺表面活性物质、nCPAP、高频振荡通气、NO 吸入治疗已经成为新生儿呼吸衰竭的主要救治手段,但新生儿呼吸衰竭的病死率仍然较高。
Abstract
Objective To investigate the clinical epidemiological characteristics of neonatal respiratory failure in 1 108 neonates, and to provide a reference for improvement in clinical treatment and multicenter clinical studies. Methods The clinical data of 1 108 neonates with respiratory failure were collected with questionnaires, and statistical analysis was performed for the epidemiological indices including primary diseases, clinical therapeutic methods, treatment outcome, and fatality. Results In all the neonates with respiratory failure, the median gestational age was 37 weeks +1 day, the median birth weight was 2 600 g, the median age in days on admission to neonatal intensive care unit was 0.71 days (17 hours), and the boy/girl ratio was 3.1:1. The major primary diseases were respiratory distress syndrome (30.51%), pulmonary infection/sepsis (23.55%), and wet lung (13.18%). Of all the neonates, 48.64% received nasal continuous positive airway pressure (nCPAP), 12.81% received high-frequency oscillatory ventilation, 13.45% received pulmonary surfactant, and 8.66% received nitric oxide inhalation therapy. The fatality was 24.19%. Conclusions The major primary disease for neonatal respiratory failure is respiratory distress syndrome. Pulmonary surfactant, nCPAP, high-frequency oscillatory ventilation, and nitric oxide inhalation therapy are major therapeutic methods for neonatal respiratory failure, but neonatal respiratory failure still has a high fatality.
关键词
呼吸衰竭 /
流行病学特征 /
新生儿
Key words
Respiratory failure /
Epidemiological characteristics /
Neonate
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Angus DC, Linde-Zwirble WT, Clermont G, et al. Epidemiology of neonatal respiratory failure in the United States: projections from California and New York[J]. Am J Respir Crit Care Med, 2001, 164(7): 1154-1160.
[2] Rubaltelli FF, Bonafe L, Tangucci M, et al. Epidemiology of neonatal acute respiratory disorders. A multicenter study on incidence and fatality rates of neonatal acute respiratory disorders according to gestational age, maternal age, pregnancy complications and type of delivery. Italian Group of Neonatal Pneumology[J]. Biol Neonate, 1998, 74(1): 7-15.
[3] Wang H, Gao X, Liu C, et al. Morbidity and mortality of neonatal respiratory failure in China: surfactant treatment in very immature infants[J]. Pediatrics, 2012, 129(3): e731-e740.
[4] Qian L, Liu C, Zhuang W, et al. Neonatal respiratory failure: a 12-month clinical epidemiologic study from 2004 to 2005 in China[J]. Pediatrics, 2008, 121(5): e1115-e1124.
[5] 李文静, 刘翠青, 马莉. 河北省儿童医院新生儿呼吸衰竭 的前瞻性临床流行病学调查[J]. 中国当代儿科杂志, 2008, 10(3): 307-310.
[6] 金汉珍, 黄德珉, 宫希吉. 实用新生儿学[M]. 第3 版. 北京: 人民卫生出版社, 2002: 383-388.
[7] Mage DT, Donner EM. The fifty percent male excess of infant respiratory mortality[J]. Acta Paediatr, 2004, 93(9): 1210-1215.
[8] Clark RH. The epidemiology of respiratory failure in neonates born at an estimated gestational age of 34 weeks or more[J]. J Perinatol, 2005, 25(4): 251-257.
[9] Horbar JD, Badger GJ, Carpenter JH, et al. Trends in mortality and morbidity for very low birth weight infants, 1991-1999[J]. Pediatrics, 2002, 110(1 Pt 1): 143-151.
[10] Roberts CL, Badgery-Parker T, Algert CS, et al. Trends in use of neonatal CPAP: a population-based study[J]. BMC Pediatr, 2011, 11: 89.
[11] 郭艳梅, 刘翠青. 河北省儿童医院早产儿呼吸衰竭回顾性流 行病学研究[J]. 河北医药, 2012, 34(12): 1805-1807.
[12] 邱其周, 肖毅, 刘仁红, 等. 高频振荡通气治疗新生儿呼吸 衰竭疗效观察[J]. 国际呼吸杂志, 2013, 33(8): 597-599.
[13] Muraca MC, Negro S, Sun B, et al. Nitric oxide in neonatal hypoxemic respiratory failure[J]. J Matern Fetal Neonatal Med, 2012, 25 Suppl 1: 47-50.
[14] Wang YF, Liu CQ, Gao XR, et al. Effects of inhaled nitric oxide in neonatal hypoxemic respiratory failure from a multicenter controlled trial[J]. Chin Med J (Engl), 2011, 124(8): 1156-1163.
[15] 郭艳梅, 刘翠青. 河北省儿童医院新生儿呼吸衰竭的临床流 行病学特点[J]. 中华围产医学杂志, 2012, 15(11): 670-675.
[16] 郭艳梅, 刘翠青. 新生儿呼吸衰竭临床流行病学研究进展[J]. 中华围产医学杂志, 2012, 15(4): 250-253.
[17] 许平, 贾焕荣, 杨玉军, 等. 新生儿呼吸衰竭870 例临床流 行病学分析[J]. 中国新生儿科杂志, 2013, 28(3): 172-176.
[18] Ma L, Liu C, Wang Y, et al. Mortality of neonatal respiratory failure related to socioeconomic factors in Hebei province of China[J]. Neonatology, 2011, 100(1): 14-22.
基金
国家科技支撑计划(2012BAI04B04);湖南省卫生厅课题(C2009012);湖南中医药大学校级青年教师科研基金课题(99820001-185)。
PDF(1118 KB)
